Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Rockefeller University presents new LATS1 inhibitors

Sep. 1, 2021

Japanese researchers synthesize new PROTACs for cancer

Sep. 1, 2021

Arbutus Biopharma identifies PD-L1 antagonists

Sep. 1, 2021

Fileclo Sp zoo discloses new compounds for cancer

Sep. 1, 2021

Eternity Bioscience patents new ADAMTS inhibitors

Sep. 1, 2021

Genexine divulges new anti-PD-L1 fusion proteins

Aug. 31, 2021

U.K. researchers synthesize new antifungals

Aug. 31, 2021

TroBio Therapeutics presents new compounds for cancer

Aug. 31, 2021

Mindset Pharma patents 5-HT2A receptor agonists

Aug. 31, 2021

Janssen Biotech divulges DHODH inhibitors

Aug. 31, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...